Cingulate Extends Chief Medical Officer's Trial Period
Cingulate has extended the trial period for Matthew N. Brams' full-time employment as Executive Vice President and Chief Medical Officer until December 31, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.